MedTrace Logo

The Drug Facts Box: Helping Consumers Understand Drugs for Risk Reduction

NCT00753857 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2008-09-17

No results posted yet for this study

Summary

RATIONALE:

The way in which information about a drug is provided may affect the ability of patients and doctors to understand how a drug works and the side effects of the drug.

PURPOSE:

This randomized trial is studying how well a drug facts page works compared with a short drug summary in helping patients and doctors understand medical information.

Conditions

  • Healthy

Interventions

OTHER

Drug Facts Box

Educational intervention of 1 page summary of drug efficacy and side effects

OTHER

Standard Brief Summary

Ads consisted of the standard second page called the brief summary

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • White River Junction Veterans Affairs Medical Center

    lead FED

Principal Investigators

  • Steven Woloshin, MD, MS · Dartmouth Medical School; VA Medical Center (WRJ)

  • Lisa M Schwartz, MD, MS · Dartmouth Medical School, VA Medical Center (WRJ)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2007-05-31
Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00753857 on ClinicalTrials.gov